Evidence map›Paper›PMID 36516783›Full record

ArticleCell reports2022

Interspecies recombination, not de novo mutation, maintains virulence after β-lactam resistance acquisition in Streptococcus pneumoniae.

Andrew T Nishimoto, Tina H Dao, Qidong Jia, Juan C Ortiz-Marquez, Haley Echlin, Peter Vogel, Tim van Opijnen, Jason W Rosch

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A mini review of genome-predicted β-lactam susceptibility inFrontiers in cellular and infection microbiology · 2026
    Review
  5. Penicillin-Binding Proteins inAntibiotics (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Clinical microbiology reviews · 2025
    Review
  8. Amoxicillin-non-susceptibleAntimicrobial agents and chemotherapy · 2025
    Observational
  9. Article
  10. Biological puzzles solved by usingJournal of bacteriology · 2024
    Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Andrew T NishimotoDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Tina H DaoDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Qidong JiaDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Juan C Ortiz-MarquezDepartment of Biology, Boston College, Boston, MA 02467, USA.
Haley EchlinDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Peter VogelDepartment of Pathology and Veterinary Pathology Core, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Tim van OpijnenDepartment of Biology, Boston College, Boston, MA 02467, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Jason W RoschDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: jason.rosch@stjude.org.
St. Jude Children's Research Hospital · USBoston College · US

Funding

Predicting the emergence of antibiotic resistance through multi-omics approaches and Immune System-surveillanU01AI124302 · NIAID · BOSTON COLLEGE · PI BENTO, JOSE, COOPER, VAUGHN · 2016 to 2020
$10.2M
NIAID NIH HHS U01 AI124302
6 · The paper itself

Abstract

As opposed to de novo mutation, β-lactam resistance in S. pneumoniae is often conferred via homologous recombination during horizontal gene transfer. We hypothesize that β-lactam resistance in pathogenic streptococci is restricted to naturally competent species via intra-/interspecies recombination due to in vivo fitness trade-offs of de novo penicillin-binding protein (PBP) mutations. We show that de novo mutant populations have abrogated invasive disease capacity and are difficult to evolve in vivo. Conversely, serially transformed recombinant strains efficiently integrate resistant oral streptococcal DNA, gain penicillin resistance and tolerance, and retain virulence in mice. Large-scale changes in pbp2X, pbp2B, and non-PBP-related genes occur in recombinant isolates. Our results indicate that horizontal transfer of β-lactam resistance engenders initially favorable or minimal cost changes in vivo compared with de novo mutation(s), underscoring the importance of recombination in the emergence of β-lactam resistance and suggesting why some pathogenic streptococci lacking innate competence remain universally susceptible.

Indexed as

Pneumococcal InfectionsStreptococcus pneumoniaeAnimalsAnti-Bacterial AgentsBacterial Proteinsbeta-Lactam ResistanceGene Transfer, HorizontalMiceMicrobial Sensitivity TestsMutationPenicillin-Binding ProteinsVirulenceAnti-Bacterial AgentsBacterial ProteinsPenicillin-Binding Proteinsantibiotic resistanceantibiotic toleranceCP: Microbiologyfitnesshorizontal gene transferinterspecies recombinationpneumococciS. pneumoniaestreptococcivirulenceβ-lactam

Identifiers

PMID36516783
PMCPMC9850807
OpenAlexW4311311316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.